16th Oct 2015 07:00
16 October 2015
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Annual Report and Accounts
Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that the Annual Report and Accounts for the year ended 30 June 2015 are available on the Company's website in the Investor Relations section. They can be located at:
www.allergytherapeutics.com/media/1216/atl-financial-statements-june-2015.pdf
Printed copies of the Annual Report and Accounts for the year end 30 June 2015 will be posted to shareholders together with the Notice of the Annual General Meeting on 20 October 2015.
For further information:
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer | |
Ian Postlethwaite, Finance Director | |
Panmure Gordon | +44 (0) 20 7886 2500 |
Freddy Crossley / Peter Steel / Duncan Monteith, Corporate Finance | |
Tom Salvesen, Corporate Broking | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway | |
Victoria Foster Mitchell |
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of £43 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.
Related Shares:
Allergy Thera.